A Study of the Safety and Efficacy of CNTO 328 and Bortezomib to Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2006-11-22
- Last Posted Date
- 2019-11-19
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 307
- Registration Number
- NCT00401843
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Phase 3
Completed
- Conditions
- Breast CancerNeoplasm Metastasis
- Interventions
- Drug: epoetin alfa + packed RBC transfusionOther: Standard supportive care (packed RBC transfusion)
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2018-03-19
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 2098
- Registration Number
- NCT00338286
A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment
- Conditions
- Sarcoma
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2017-10-10
- Lead Sponsor
- Janssen Research & Development, LLC
- Registration Number
- NCT00210665
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
Completed
- Conditions
- Ulcerative Colitis
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2018-07-06
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 505
- Registration Number
- NCT00207688
Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma
Phase 3
Completed
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2005-02-10
- Last Posted Date
- 2015-10-19
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 646
- Registration Number
- NCT00103506
© Copyright 2025. All Rights Reserved by MedPath